Most cited papers from Centro Studi GISED

Centro Studi GISED

What are the most cited papers from Centro Studi GISED?

The most cited paper from Centro Studi GISED is "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" (Rafael Lozano et al., 2012), with 14,344 citations. Next come "Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (9,055) and "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" (8,461).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 57 papers. Every paper with more than 106 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Rafael Lozano et al. · The Lancet Open access191 authors	Dec 2012	14,344
2	Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Christopher J L Murray et al. · The Lancet Open access362 authors	Dec 2012	9,055
3	Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet Open access358 authors	Dec 2012	8,461
4	Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors	27 Sep 2019	2,699
5	Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis Jean‐Claude Roujeau, Judith Parsells Kelly, Luigi Naldi et al. · New England Journal of Medicine	14 Dec 1995	1,473
6	Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent Renu Virmani, Giulio Guagliumi, Andrew A. Farb et al. · Circulation Open access	26 Jan 2004	1,472
7	Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study Maja Mockenhaupt, Cecile G. Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology Open access	6 Sep 2007	1,020
8	Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study Sylvia Helena Kardaun, Peggy Sekula, L. Valeyrie‐Allanore et al. · British Journal of Dermatology	16 Jul 2013	1,018
9	Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Monica Galli, Davide Luciani, Guido Bertolini et al. · Blood Review	12 Feb 2003	974
10	Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study Luigi Naldi et al. · Journal of Investigative Dermatology Open access	27 Jun 2005	645
11	Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel Sima Halevy, Pierre‐Dominique Ghislain, Maja Mockenhaupt et al. · Journal of the American Academy of Dermatology	25 Oct 2007	486
12	Product Innovation in Family versus Nonfamily Firms: An Exploratory Analysis Alfredo De Massis, Federico Fabio Frattini, Emanuele Pizzurno et al. · Journal of Small Business Management	16 Sep 2013	468
13	Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Peggy Sekula, Ariane Dunant, Maja Mockenhaupt et al. · Journal of Investigative Dermatology Open access	7 Feb 2013	449
14	Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis É. Sbidian, Anna Chaimani, Ignacio García-Doval et al. · Cochrane Database of Systematic Reviews Open access	22 Dec 2017	434
15	Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome Monica Galli, Davide Luciani, Guido Bertolini et al. · Blood	23 Jun 2003	419
16	Prevalence of contact allergy in the general population in different European regions Thomas Ludwig Diepgen, Robert F. Ofenloch, M. Bruze et al. · British Journal of Dermatology	15 Sep 2015	354
17	Transfer of Growth Factor Receptor mRNA Via Exosomes Unravels the Regenerative Effect of Mesenchymal Stem Cells Susanna Tomasoni, Lorena Longaretti, Cinzia Rota et al. · Stem Cells and Development Open access	19 Oct 2012	343
18	Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice Philip M. Urban, Anthony Gershlick, Giulio Guagliumi et al. · Circulation	14 Mar 2006	322
19	Epidemiology of Psoriasis Luigi Naldi · Current Drug Targets - Inflammation & Allergy	Jun 2004	320
20	Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease Piero Ruggenenti, Andrea Remuzzi, Patrizia Ondei et al. · Kidney International Open access	13 Jun 2005	269
21	Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults Anna Di Landro, Simone Cazzaniga, Fabio Parazzini et al. · Journal of the American Academy of Dermatology	5 Mar 2012	258
22	Methicillin-resistant Staphylococcus aureus: the superbug Giuseppe Ippolito, Sebastiano Leone, F. Lauria et al. · International Journal of Infectious Diseases Open access	21 Sep 2010	248
23	ERS statement on protracted bacterial bronchitis in children Ahmad Kantar, Anne B. Chang, Mike D. Shields et al. · European Respiratory Journal Open access	Aug 2017	238
24	Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis Luigi Naldi, Antonio Addis, Sergio Chimenti et al. · Dermatology Open access	2008	228
25	Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen Deborah A. Shackelford, Dean L. Mann, Jon J. van Rood et al. · Proceedings of the National Academy of Sciences Open access	Jul 1981	202
26	Uremic Bleeding: Closing the Circle After 30 Years of Controversies? Marina Noris, Giuseppe Remuzzi · Blood	15 Oct 1999	202
27	Diet and physical exercise in psoriasis: a randomized controlled trial Luigi Naldi, Andrea Conti, Simone Cazzaniga et al. · British Journal of Dermatology	14 Nov 2013	199
28	Dementia After First Stroke Bruno Censori, Ornella Manara, Cristina Agostinis et al. · Stroke	Jul 1996	199
29	Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis Shawn G. Kwatra et al. · New England Journal of Medicine Open access	25 Oct 2023	189
30	Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study Martino Introna, Gianmaria Borleri, Elena Conti et al. · Haematologica Open access	Jul 2007	189
31	The clinical spectrum of psoriasis Luigi Naldi, Daniele Mario Gambini · Clinics in Dermatology	Nov 2007	188
32	Seborrheic Dermatitis Luigi Naldi, Alfredo Rebora · New England Journal of Medicine	21 Jan 2009	187
33	Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks Luigi Naldi, Christopher E.M. Griffiths · British Journal of Dermatology	Apr 2005	182
34	Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: Results of a case-control study Luigi Naldi, Lorenzo Peli, Fabio Parazzini et al. · Journal of the American Academy of Dermatology	Mar 2001	178
35	Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study Leonardo Emberti Gialloreti, Monica Merito, Patrizio Pezzotti et al. · BMC Infectious Diseases Open access	3 Aug 2010	176
36	Total Versus Subtotal Gastrectomy Federico Bozzetti, Ettore Marubini, Giuliano Bonfanti et al. · Annals of Surgery Open access	Nov 1997	176
37	The global state of psoriasis disease epidemiology: a workshop report Christopher E.M. Griffiths, Joelle M. van der Walt, Darren M. Ashcroft et al. · British Journal of Dermatology Open access	28 May 2017	173
38	Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study Satveer K. Mahil et al. · Journal of Allergy and Clinical Immunology Open access140 authors	16 Oct 2020	160
39	Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland Michael Benzaquen, Luca Borradori, P. Berbis et al. · Journal of the American Academy of Dermatology Open access	21 Dec 2017	159
40	l -Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species Marina Noris, Marta Todeschini, Paola Cassis et al. · Hypertension Open access	27 Jan 2004	156
41	Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Dana Bryazka et al. · The Lancet Public Health Open access1,009 authors	Oct 2024	148
42	Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes Marta Franceschetti, Alice Pievani, Gianmaria Borleri et al. · Experimental Hematology Open access	17 Apr 2009	142
43	Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update Paolo Gisondi, Stefano Piaserico, Carolina Russo Bordin et al. · Journal of the European Academy of Dermatology and Venereology Open access	25 Jun 2020	138
44	Cerebrospinal fluid study in paraneoplastic syndromes Dimitri Psimaras, Alain Carpentier, Carlotta Rossi et al. · Journal of Neurology Neurosurgery & Psychiatry	25 Mar 2009	133
45	Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate Chiara Capelli, Elisa Gotti, Marina Morigi et al. · Cytotherapy	18 Mar 2011	124
46	Sirolimus-Eluting Stent Implanted in Human Coronary Artery for 16 Months Giulio Guagliumi, Andrew A. Farb, Giuseppe Musumeci et al. · Circulation	10 Mar 2003	123
47	Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Giovanni Barosi, Achille Ambrosetti, Antonietta Centra et al. · PubMed	15 May 1998	121
48	Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions Massimo Camerlingo, Pietro Salvi, Giorgio Belloni et al. · Stroke Open access	14 Oct 2005	120
49	Prevalence of skin disease in a population-based sample of adults from five European countries Åke Svensson, Robert F. Ofenloch, M. Bruze et al. · British Journal of Dermatology Open access	16 Dec 2017	117
50	RISK OF NONMELANOMA SKIN CANCER IN ITALIAN ORGAN TRANSPLANT RECIPIENTS. A REGISTRY-BASED STUDY Luigi Naldi, Anna Belloni Fortina, Silvia Lovati et al. · Transplantation	Nov 2000	117

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.